Form 4: Oxbridge Re Director and 10% Owner Reports Pre-Planned Share Sales
Insider Trading Report
Allan S. Martin, a Director and 10% Owner of Oxbridge Re Holdings Ltd, reported multiple sales of Ordinary Shares in early July 2025, executed under a Rule 10b5-1 trading plan.
Summary
- Allan S. Martin, a Director and 10% Owner of Oxbridge Re Holdings Ltd (OXBR), reported multiple sales of Ordinary Shares between July 9, 2025, and July 11, 2025.
- On July 9, 2025, 500 Ordinary Shares were sold directly at $2.06 per share, and 500 Ordinary Shares were sold indirectly through the Martin Family Foundation, Inc. at $2.1145 per share.
- On July 10, 2025, an additional 1,000 Ordinary Shares were sold indirectly through the Martin Family Foundation, Inc. at $2.065 per share.
- On July 11, 2025, 2,000 Ordinary Shares were sold indirectly through the Martin Family Foundation, Inc. at $2.2233 per share.
- These transactions were conducted pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
- Following these transactions, Allan S. Martin beneficially owns a total of 412,124 Ordinary Shares, comprising 239,131 shares held directly (jointly with wife), 68,770 shares held indirectly through Fleur de Lis Partners, LLLP, and 104,223 shares held indirectly through the Martin Family Foundation, Inc.
Sentiment
Score: 5
Explanation: The sale of shares by a director and 10% owner is generally a neutral to slightly negative signal, but the disclosure that it was executed under a Rule 10b5-1 plan mitigates concerns, suggesting a pre-planned liquidity event rather than a reaction to new negative information.
Positives
- The reported share sales were executed under a Rule 10b5-1(c) plan, indicating that these were pre-scheduled transactions rather than a reaction to new, negative material non-public information.
Negatives
- A Director and 10% Owner selling shares, even under a pre-planned program, can be perceived as a reduction in insider alignment with shareholder interests.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compliance Disclosure | The transactions were conducted under a Rule 10b5-1(c) plan, which is a corporate governance mechanism allowing insiders to pre-arrange trades to avoid accusations of trading on material non-public information. | 07/09/2025 | Enhances transparency and provides an affirmative defense against insider trading allegations for the reported transactions. |
| Regulatory Filing | The filing itself is a Statement of Changes in Beneficial Ownership pursuant to Section 16(a) of the Securities Exchange Act of 1934, a standard regulatory requirement for insiders. | 07/11/2025 | Ensures compliance with SEC reporting requirements for insider transactions. |
Related Party Transactions
- Indirect beneficial ownership of 68,770 Ordinary Shares held in the name of Fleur de Lis Partners, LLLP, where Mr. Martin serves as the general partner with voting and investment power.
- Indirect beneficial ownership of 104,223 Ordinary Shares held in the name of the Martin Family Foundation, Inc., where Mr. Martin is one of the directors with shared voting and investment power.
Stakeholder Impact
- Shareholders may interpret the sales by a significant insider as a potential signal, although the 10b5-1 plan mitigates concerns about opportunistic selling.
Key Dates
| Date | Description |
|---|---|
| 07/09/2025 | Sale of 500 Ordinary Shares directly at $2.06 and 500 Ordinary Shares indirectly via Martin Family Foundation, Inc. at $2.1145. |
| 07/10/2025 | Sale of 1,000 Ordinary Shares indirectly via Martin Family Foundation, Inc. at $2.065. |
| 07/11/2025 | Sale of 2,000 Ordinary Shares indirectly via Martin Family Foundation, Inc. at $2.2233. This is also the filing date of the Form 4. |
Recommendation
holdKeywords
Oxbridge Re Holdings, OXBR, Allan S. Martin, insider trading, Form 4, beneficial ownership, stock sale, 10b5-1 plan, director, 10% owner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.